HHS Adds Duchenne Muscular Dystrophy, Metachromatic Leukodystrophy to Newborn Screening Panel
The additions aim to enable earlier detection and treatment of both rare conditions, which typically aren't diagnosed until ages 4-5.
The additions aim to enable earlier detection and treatment of both rare conditions, which typically aren't diagnosed until ages 4-5.
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
Researchers demonstrate that cfDNA fragmentation patterns can effectively diagnose and stage bladder cancer, potentially reducing reliance on invasive cystoscopies.
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
The eight-minute test also shortened hospital stays by nearly two days at Froedtert Hospital, reinforcing previous multi-site evidence.